Brightcove Expands Its Unmatched, End-to-End Video Platform With the Launch of Cloud Playout
Brightcove Inc. (NASDAQ: BCOV), the global leader in video for business, today announced the launch of Brightcove Cloud Playout, a new feature that enhances Brightcove’s end-to-end video platform and makes it one of the few online video providers to offer this capability. Brightcove helps propel businesses forward through video, offering a complete video ecosystem with cutting edge technology, tools, incomparable knowledge, and customer support. The launch of Cloud Playout strengthens Brightcove’s Technology and Engineering Emmy® Award-winning offerings by enabling customers to save even more time and money by consolidating all video needs on a single platform.
Brightcove Cloud Playout is a brand new feature of Brightcove Video Cloud that enables content owners and organizations to quickly and seamlessly program a scheduled playout of both on-demand video assets and live footage or events into a single stream. This provides a broadcast-grade “live TV” experience that leverages pre-recorded content to increase audience engagement and create new revenue opportunities. Customers also benefit from a highly streamlined workflow, as every possible video need is met within Brightcove’s singular all-inclusive platform.
Early adopters of this capability include long-time Brightcove client AMC, as well as global entertainment destination BookMyShow, and more. In March 2021, SXSW Online will be the first Brightcove customer to utilize Cloud Playout for its conference and festivals.
“Horror genre enthusiasts are die-hard fans, and with COVID-19 impacting Halloween celebrations we decided to host ShudderFest, a simulive 24-hour event just for them," said Mike Zagari, EP of ShudderFest. "With Brightcove's Cloud Playout, we were able to quickly pull together our content lineup and save time on our video workflows, as well as reach our global fan base by easily looping the event for every time zone around the world."
"As the ubiquitous platform for all things entertainment, BookMyShow offers several live event formats across music, comedy, theatricals performances and much more with the entire repertoire being available virtually both as both live events and pre-recorded ones such as Sunburn Home Festival, Rambo Circus and international artists including Willie Gomez, The Buckleys, Taylor Castro to name a few hosted on our live entertainment platform BookMyShow Online, powered by Brightcove,” said Parikshit Dar, Co-founder and Director, BookMyShow. "With Brightcove’s newest feature, Cloud Playout, we have been able to be a lot more flexible with our programming, and we finally have an end-to-end platform for our growing video needs."
“Since Brightcove’s inception, video innovation has been a key priority for us, and Cloud Playout demonstrates our commitment to providing our customers with the best technology and tools to help them succeed with video,” said Namita Dhallan, Chief Product Officer of Brightcove. “Cloud Playout is the next innovation in our platform, and by enabling customers to streamline the management and playout of content within a single solution, we’re saving them the additional costs and security risks of utilizing third party apps, while still providing the scalability to reach audiences around the globe, on their schedule.”
With over 50 industry-defining patents, Brightcove lives and breathes video. The company provides its game-changing video capabilities to over 3,300 customers globally. This roster includes industry leaders spanning verticals, from media titans like Showtime Networks and Vox Media, food and beverage giants such as Chick-Fil-A and Dunkin Brands, authorities in entertainment like the Academy of Motion Picture Arts and Sciences, virtual education company MasterClass, sports partners like the USGA, and many more.
About Brightcove
When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organizations in more than 70 countries across the globe to touch audiences in bold and innovative ways.
Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the world’s most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business.™
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005733/en/
Contact information
Meredith Duhaime
Senior PR Manager, Brightcove
mduhaime@brightcove.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 01:49:00 EET | Press release
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive Officer, Lattice Semiconductor. The annual GSA Awards celebrate the accomplishments of the semiconductor indu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom